Company intelligence / Profile preview

广东凯仲生物科技

Guangzhou, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Guangdong Kaizhong Biotechnology is a Chinese biopharmaceutical company focused on the research, development, and industrialization of mesenchymal stem cell (MSC) therapies. The company specializes in developing standardized, high-quality stem cell products for a variety of clinical applications, including liver diseases and autoimmune disorders. Kaizhong Biotech operates advanced R&D facilities and a GMP-compliant manufacturing base to support its pipeline of regenerative medicine candidates. By leveraging its proprietary cell processing technologies, the company aims to provide innovative solutions for chronic and life-threatening conditions that currently lack effective treatments.

Therapeutic areas: GastroenterologyImmunology
Modalities: Cell therapyBiologicStem cell therapy
Industry: Biotech

Beyond the preview

Go deeper on 广东凯仲生物科技.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 广东凯仲生物科技.

Explore the full profile